Bill Reid
CISO and VP, Security and Privacy @ Resilience
Seattle, United States
Bill Reid is a startup investor at Resilience in Seattle. Bill is Senior Vice President of Product Management and Chief Information Security Officer, where he oversees the strategy of SCI’s product portfolio as well as the company's security and privacy functions. Bill joins SCI from a long background in healthcare and health technology. He has held a number of leadership roles at companies includingGroup Health Cooperative, Microsoft and Numera. At Group Health, his Care Management organization introduced groundbreaking methods for management of inpatients and chronic care groups, resulting in significant savings and improvements in quality. During his tenure at Microsoft, Bill was a leading expert on HIPAA in the Healthcare National Consulting Practice, and was key member of the HealthVault and Amalga teams, including partnering with the Mayo Clinic to build the Mayo Clinic Health Manager application, which brought together the Microsoft platform with the expertise of the Mayo Clinic.At Numera, a medical device and remote patient monitoring company, he led the product management of its FDA Class 2 system, and served as both Chief Privacy and Security Officer. He is board certified in Healthcare Management as a Fellow of the American College of Healthcare Executives, and was a founding member, and past president, of the Washington Chapter. Bill serves as advisor to several technology companies and has been a mentor for healthcare startup companies in both TechStars and DreamIT Ventures. Reid has a Master’s of Science from Tufts University, and a BA from the University of Pennsylvania, as well as a certificate in healthcare ethics from the University of Washington School of Medicine.
Last updated:
For AI agents: llms.txt
About Resilience
Resilience is a technology-driven biomanufacturing company committed to expanding access to complex medicines, including biologics, vaccines, nucleic acids, and cell and gene therapies. The company is creating a sustainable network of advanced, end-to-end manufacturing solutions to ensure that today's and tomorrow's treatments can beproduced rapidly, safely, and at scale. By continuously innovating in biopharmaceutical manufacturing and development, Resilience enables its partners to focus on breakthrough discoveries that enhance patient outcomes while safeguarding biopharmaceutical supply chains against future disruptions.
Resilience Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Bill Reid
CISO and VP, Security and Privacy
|
|||
Eytan Abraham
VP, Head of Cell Therapy Franchise
|
|||
Rahul Singhvi
Co-Founder & CEO
|
|||
Ross Leimberg
Senior Director of Business Development
|
|||
Sandy Mahatme
President, COO and CFO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
